TrialCancer2021
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
Iman Abou Dalle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
TrialCancer2021
Iman Abou Dalle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.